{"id":"https://openalex.org/W2982651237","doi":"https://doi.org/10.1186/s12931-019-1187-7","title":"Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)","display_name":"Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)","publication_year":2019,"publication_date":"2019-10-30","ids":{"openalex":"https://openalex.org/W2982651237","doi":"https://doi.org/10.1186/s12931-019-1187-7","mag":"2982651237","pmid":"https://pubmed.ncbi.nlm.nih.gov/31666076","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6822411"},"language":"en","primary_location":{"id":"doi:10.1186/s12931-019-1187-7","doi":"https://doi.org/10.1186/s12931-019-1187-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-019-1187-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1187-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1187-7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112141491","display_name":"James F. Donohue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James F. Donohue","raw_affiliation_strings":["Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025257736","display_name":"Edward Kerwin","orcid":"https://orcid.org/0000-0002-1697-9036","observed_orcids":["https://orcid.org/0000-0002-1697-9036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Kerwin","raw_affiliation_strings":["Clinical Research Institute of Southern Oregon, PC, Medford, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Institute of Southern Oregon, PC, Medford, OR, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059374169","display_name":"Sanjay Sethi","orcid":"https://orcid.org/0000-0003-0809-7604","observed_orcids":["https://orcid.org/0000-0003-0809-7604"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjay Sethi","raw_affiliation_strings":["University at Buffalo, State University of New York, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University at Buffalo, State University of New York, Buffalo, NY, USA","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034939345","display_name":"Brett Haumann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett Haumann","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061651945","display_name":"Srikanth Pendyala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srikanth Pendyala","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072529540","display_name":"Lorna Dean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorna Dean","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102873284","display_name":"Chris N. Barnes","orcid":"https://orcid.org/0000-0002-2237-4842","observed_orcids":["https://orcid.org/0000-0002-2237-4842"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris N. Barnes","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109142964","display_name":"Edmund J. Moran","orcid":"https://orcid.org/0000-0001-5066-4866","observed_orcids":["https://orcid.org/0000-0001-5066-4866"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edmund J. Moran","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091161510","display_name":"Glenn Crater","orcid":"https://orcid.org/0000-0002-1159-1323","observed_orcids":["https://orcid.org/0000-0002-1159-1323"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Glenn Crater","raw_affiliation_strings":["Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA. gcrater@theravance.com","Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":"https://orcid.org/0000-0002-1159-1323","affiliations":[{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA. gcrater@theravance.com","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5091161510"],"corresponding_institution_ids":["https://openalex.org/I4210133216"],"apc_list":{"value":2570,"currency":"USD","value_usd":2570},"apc_paid":{"value":2570,"currency":"USD","value_usd":2570},"fwci":2.2031,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.88397129,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"20","issue":"1","first_page":"241","last_page":"241"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/revefenacin","display_name":"revefenacin","score":1.0},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9829999804496765},{"id":"https://openalex.org/keywords/long-acting-muscarinic-antagonist","display_name":"long-acting muscarinic antagonist","score":0.9890000224113464},{"id":"https://openalex.org/keywords/nebulized-bronchodilators","display_name":"nebulized bronchodilators","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tiotropium","display_name":"tiotropium","score":0.9200000166893005},{"id":"https://openalex.org/keywords/trough-fev1","display_name":"trough FEV1","score":0.9150000214576721},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/health-status-outcomes","display_name":"health status outcomes","score":0.7910000085830688},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.7770000100135803},{"id":"https://openalex.org/keywords/long-acting-beta-agonists","display_name":"long-acting beta2-agonists","score":0.871999979019165},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9349262118339539},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.8973569273948669},{"id":"https://openalex.org/C2776968687","wikidata":"https://www.wikidata.org/wiki/Q424316","display_name":"Tiotropium bromide","level":4,"score":0.6540525555610657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6311865448951721},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.52058345079422},{"id":"https://openalex.org/C2776723954","wikidata":"https://www.wikidata.org/wiki/Q3001265","display_name":"Muscarinic antagonist","level":4,"score":0.5036374926567078},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.4775160849094391},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47062233090400696},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.4545856714248657},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44057151675224304},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.33287858963012695},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.17498916387557983},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.08386072516441345},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.07859593629837036},{"id":"https://openalex.org/C165637977","wikidata":"https://www.wikidata.org/wiki/Q11067835","display_name":"Diffusing capacity","level":4,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12931-019-1187-7","doi":"https://doi.org/10.1186/s12931-019-1187-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-019-1187-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1187-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5799558","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6822411","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6822411","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6822411","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respir Res","raw_type":"Text"},{"id":"pmid:31666076","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31666076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory research","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:doaj.org/article:198bfe3495a340e7a38a0033b3384475","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/198bfe3495a340e7a38a0033b3384475","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12931-019-1187-7","doi":"https://doi.org/10.1186/s12931-019-1187-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-019-1187-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1187-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314713","display_name":"Theravance Biopharma US","ror":"https://ror.org/03a6z4w08"},{"id":"https://openalex.org/F4320316473","display_name":"Mylan","ror":"https://ror.org/04nsw4151"},{"id":"https://openalex.org/F5566091058","display_name":"Department of Industrial Engineering, School of Engineering, Southern Illinois University Edwardsville","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2982651237.pdf","grobid_xml":"https://content.openalex.org/works/W2982651237.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W2043705811","https://openalex.org/W2044142645","https://openalex.org/W2077523026","https://openalex.org/W2129760701","https://openalex.org/W2328612168","https://openalex.org/W2564042923","https://openalex.org/W2760351771","https://openalex.org/W2762828327","https://openalex.org/W2766794969","https://openalex.org/W2770883613","https://openalex.org/W2941013947","https://openalex.org/W2946624880","https://openalex.org/W4245029253","https://openalex.org/W4292528167"],"related_works":["https://openalex.org/W3024372630","https://openalex.org/W2946624880","https://openalex.org/W3207664220","https://openalex.org/W2894785718","https://openalex.org/W3156868760","https://openalex.org/W3145382012","https://openalex.org/W2766794969","https://openalex.org/W2765521721","https://openalex.org/W6977512822","https://openalex.org/W2780416962"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Revefenacin":[2],"is":[3],"a":[4,41,52,102,268],"long-acting":[5,187],"muscarinic":[6],"antagonist":[7],"that":[8],"was":[9,47,181],"recently":[10],"approved":[11],"for":[12,152,165,257,271],"the":[13,28,75,112,161,174,272],"nebulized":[14,273],"treatment":[15,114,240,274],"of":[16,30,118,176,275],"chronic":[17],"obstructive":[18],"pulmonary":[19],"disease":[20],"(COPD).":[21],"Although":[22],"shorter":[23],"duration":[24],"studies":[25],"have":[26],"documented":[27],"efficacy":[29,35,60],"revefenacin":[31,46,67,95,153,177,259],"in":[32,64,101,133,138,183,210,238,248],"COPD,":[33],"longer-term":[34],"has":[36],"not":[37,198],"been":[38],"described.":[39],"In":[40,79,171],"recent":[42],"52-week":[43,76,83,113],"safety":[44],"trial,":[45],"well":[48,121],"tolerated":[49],"and":[50,61,160,228,230,251],"had":[51],"favorable":[53],"benefit-risk":[54],"profile.":[55],"Here":[56],"we":[57],"report":[58],"exploratory":[59],"health":[62,213,253],"outcomes":[63,215,254],"patients":[65,184,195,276],"receiving":[66],"175":[68,96,154],"\u03bcg":[69,72,97,100,155],"or":[70,98,105,190],"88":[71,99],"daily":[73],"during":[74],"trial.":[77],"Methods":[78],"this":[80],"randomized,":[81],"parallel-group,":[82],"trial":[84],"(NCT02518139),":[85],"1055":[86],"participants":[87],"with":[88,189,194,277],"moderate":[89],"to":[90],"very":[91],"severe":[92],"COPD":[93,222,226],"received":[94],"double-blind":[103],"manner,":[104],"open-label":[106],"active":[107],"control":[108],"tiotropium.":[109],"Results":[110],"Over":[111],"period,":[115],"both":[116],"doses":[117],"revefenacin,":[119],"as":[120,122,267],"tiotropium,":[123],"elicited":[124],"significant":[125,205],"(all":[126],"p":[127],"<":[128,207],"0.0003)":[129],"improvements":[130,209,245],"from":[131,150,157,168,234,246],"baseline":[132,247],"trough":[134,143,162,179,249],"forced":[135],"expiratory":[136],"volume":[137],"1":[139],"s":[140],"(FEV1).":[141],"The":[142],"FEV1":[144,163,180,250],"profile":[145,164],"(least":[146],"squares":[147],"mean":[148],"change":[149],"baseline)":[151],"ranged":[156,167],"52.3\u2013124.3":[158],"mL":[159],"tiotropium":[166],"79.7\u2013112.8":[169],"mL.":[170],"subgroup":[172],"comparisons,":[173],"effect":[175],"on":[178],"comparable":[182],"taking":[185,199],"concomitant":[186],"\u03b2-agonists,":[188],"without":[191],"inhaled":[192],"corticosteroids,":[193],"who":[196],"were":[197,203,255],"these":[200],"medications.":[201],"There":[202],"statistically":[204],"(p":[206],"0.05)":[208],"all":[211,239],"measured":[212],"status":[214],"(evaluated":[216],"using":[217],"St.":[218],"George\u2019s":[219],"Respiratory":[220],"Questionnaire,":[221],"Assessment":[223],"Test,":[224],"Clinical":[225],"Questionnaire":[227],"Baseline":[229],"Transition":[231],"Dyspnea":[232],"Index)":[233],"3":[235],"months":[236],"onward,":[237],"arms.":[241],"Conclusions":[242],"Significant":[243],"sustained":[244],"respiratory":[252],"demonstrated":[256],"175-\u03bcg":[258],"over":[260],"52":[261],"weeks,":[262],"further":[263],"supporting":[264],"its":[265],"use":[266],"once-daily":[269],"bronchodilator":[270],"COPD.":[278],"Trial":[279],"registration":[280],"NCT02518139":[281],";":[282],"Registered":[283],"5":[284],"August":[285],"2015.":[286]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-11-08T00:00:00"}